University of Hawaii
Honolulu, Hawaii, United States
Land-grant university in Honolulu, Hawaii
2500 Campus Rd, Honolulu, HI 96822
About University of Hawaii
The University of Hawaiʻi at Mānoa is a public land-grant research university in Mānoa, a neighborhood in Honolulu, Hawaii, United States. It is the flagship campus of the University of Hawaiʻi system and houses the main offices of the system.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
47
University of Hawaii
14
Children's Oncology Group
11
National Cancer Institute (NCI)
7
NSABP Foundation Inc
4
Radiation Therapy Oncology Group
4
Alliance for Clinical Trials in Oncology
3
ECOG-ACRIN Cancer Research Group
3
Health Decisions
3
Novartis
2
AIDS Clinical Trials Group
1
Clinical Trials at University of Hawaii
During the past decade, University of Hawaii conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 33 clinical trials were completed, i.e. on
average, 220% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
1999-09-01
Completed
2,000
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)
1996-09-01
Completed
1,292
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
1998-10-01
Completed
164
A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months
1997-06-01
Completed
1,750
The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV Therapy
2003-12-01
Completed
108
Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects
Completed
300
Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV Therapy
1997-10-01
2007-04-01
Completed
636
Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320
2003-06-01
Completed
440
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Hawaii" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 47 trials, followed by "University of Hawaii" with 14 trials
sponsored, "Children's Oncology Group" with 11 trials sponsored, "National Cancer Institute (NCI)" with 7 trials sponsored and "NSABP Foundation Inc"
with 7 trials sponsored. Other sponsors include 32 different institutions and
companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Hawaii"
#1 collaborator was "National Cancer Institute (NCI)" with 25 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator and "University of Hawaii" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were
collaborators in the rest 55 trials.
Clinical Trials Conditions at University of Hawaii
According to Clinical.Site data, the most researched conditions in "University of Hawaii" are
"HIV Infections" (52 trials), "Breast Cancer" (5 trials), "Diabetes Mellitus, Type 2" (4 trials), "Contraception" (3 trials) and "HIV Seronegativity" (3 trials). Many other conditions were trialed in "University of Hawaii" in a lesser frequency.
Clinical Trials Intervention Types at University of Hawaii
Most popular intervention types in "University of Hawaii" are "Drug" (75 trials), "Other" (18 trials), "Biological" (14 trials), "Behavioral" (13 trials) and "Procedure" (9 trials). Other intervention types were less common.
The name of intervention was led by "laboratory biomarker analysis" (10 trials), "Indinavir sulfate" (8 trials), "Zidovudine" (7 trials), "cyclophosphamide" (7 trials) and "Lamivudine" (6 trials). Other intervention names were less common.
Clinical Trials Genders at University of Hawaii
The vast majority of trials in "University of Hawaii" are
98 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at University of Hawaii
Currently, there are 17 active trials in "University of Hawaii".
1 are not yet recruiting,
4 are recruiting,
11 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 86 completed trials in University of Hawaii,
1 suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in University of Hawaii, 4 "Phase 1"
clinical trials were conducted, 31 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 23 trials that are defined as “Not Applicable".
Departments of University of Hawaii
University of Hawaii has several departments that took part in Clinical trials: "Department of Native Hawaiian Health, University of Hawaii" - 5 trials, "Diabetes Research Goup University of Hawaii at Manoa" - 4 trials, "Cheryl Albright, PhD, MPH" - 2 trials
Departments List
Name
City
Trials